Cargando…
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
Pulmonary hypertension is a disease with severe consequences for the human body. There are several diseases and situations that induce pulmonary hypertension and are usually underdiagnosed. Treatments include conventional medical therapies and oral, inhaled, intravenous, and subcutaneous options. De...
Autores principales: | Pitsiou, Georgia, Zarogoulidis, Paul, Petridis, Dimitris, Kioumis, Ioannis, Lampaki, Sofia, Organtzis, John, Porpodis, Konstantinos, Papaiwannou, Antonis, Tsiouda, Theodora, Hohenforst-Schmidt, Wolfgang, Kakolyris, Stylianos, Syrigos, Konstantinos, Huang, Haidong, Li, Qiang, Turner, J Francis, Zarogoulidis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199972/ https://www.ncbi.nlm.nih.gov/pubmed/25336919 http://dx.doi.org/10.2147/DDDT.S70277 |
Ejemplares similares
-
Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014) -
A gene therapy induced emphysema model and the protective role of stem cells
por: Zarogoulidis, Paul, et al.
Publicado: (2014) -
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014) -
Lung Cancer and Eye Metastases
por: Lampaki, Sofia, et al.
Publicado: (2014) -
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
por: Petridis, Dimitris, et al.
Publicado: (2014)